Nuzenio

Breakthrough Therapy

Breakthrough Therapy news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 14 latest news signals 13 publisher sources 100/100 entity strength

Latest news

The OncFive: Top Oncology Articles for the Week of 8/2 - OncLiveOncLive · Sat, 08 Aug 2026 10:13:24 GMT InnoCare Pharma (SEHK:9969) Following Breakthrough Therapy News And The Undervalued Narrative - simplywall.stsimplywall.st · Fri, 07 Aug 2026 05:51:49 GMT FDA Grants Breakthrough Therapy Status to a Pancreatic Cancer Drug for a Mutation Found in Roughly 1 in 50 Patients - Medical DailyMedical Daily · Thu, 06 Aug 2026 12:50:07 GMT FDA Grants Breakthrough Therapy Designation to Olomorasib for KRAS G12C-Mutant Advanced Pancreatic Cancer - OncodailyOncodaily · Wed, 05 Aug 2026 13:26:29 GMT FDA grants breakthrough therapy designation to Lilly’s olomorasib - Pharmaceutical Business review -Pharmaceutical Business review - · Tue, 04 Aug 2026 19:15:28 GMT FDA Grants Breakthrough Therapy Status to Eli Lilly's Pancreatic Cancer Treatment - Investing News NetworkInvesting News Network · Tue, 04 Aug 2026 18:53:00 GMT Olomorasib Earns FDA Breakthrough Therapy in KRAS G12C+ Pancreatic Cancer - CancerNetworkCancerNetwork · Tue, 04 Aug 2026 15:38:44 GMT Lilly’s olomorasib gets FDA Breakthrough Therapy designation for pancreatic cancer - PMLiVEPMLiVE · Tue, 04 Aug 2026 10:55:00 GMT

Timeline

Sat, 08 Aug 2026 10:13:24 GMTThe OncFive: Top Oncology Articles for the Week of 8/2 - OncLive

Fri, 07 Aug 2026 05:51:49 GMTInnoCare Pharma (SEHK:9969) Following Breakthrough Therapy News And The Undervalued Narrative - simplywall.st

Thu, 06 Aug 2026 12:50:07 GMTFDA Grants Breakthrough Therapy Status to a Pancreatic Cancer Drug for a Mutation Found in Roughly 1 in 50 Patients - Medical Daily

Wed, 05 Aug 2026 13:26:29 GMTFDA Grants Breakthrough Therapy Designation to Olomorasib for KRAS G12C-Mutant Advanced Pancreatic Cancer - Oncodaily

Tue, 04 Aug 2026 19:15:28 GMTFDA grants breakthrough therapy designation to Lilly’s olomorasib - Pharmaceutical Business review -

Tue, 04 Aug 2026 18:53:00 GMTFDA Grants Breakthrough Therapy Status to Eli Lilly's Pancreatic Cancer Treatment - Investing News Network

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

Lilly8 live mentions Olomorasib6 live mentions KRAS6 live mentions FDA6 live mentions FDA Grants Breakthrough5 live mentions Therapy Designation4 live mentions Eli Lilly4 live mentions Therapy Status3 live mentions Pharmaceutical Business3 live mentions Investing News Network3 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Breakthrough Therapy.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

13 distinct publisher/source names are currently connected to this entity page.